연구성과로 돌아가기
JCR 2024 저널 목록 (1258 / 2104)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Leadership in Health Services | EMERALD GROUP PUBLISHING LTD | 1751-1879 | 1751-1887 | ESCI | HEALTH POLICY & SERVICES | 770 | 1.8 | Q3 | 64.1 | 35.9 | 80/124 | 2.1 | Q3 | 1.7 | 0.3 | 0.70 | 75/124 | Q3 | 39.92 | 0.001 | 0.153 | 0.445 | Q4 | 36 | 88.9% | 5.6 | 7.0 | 32 | 18.4% | 2025-08-05 16:03:25 | 바로가기 |
| MEDICAL MYCOLOGY | OXFORD UNIV PRESS | 1369-3786 | 1460-2709 | SCIE | MYCOLOGY | 5,741 | 2.3 | Q3 | 64.1 | 35.9 | 21/32 | 2.7 | Q3 | 2.2 | 0.7 | 0.86 | 12/32 | Q2 | 64.06 | 0.004 | 0.910 | 0.739 | Q2 | 133 | 88.0% | 8.6 | 6.8 | 117 | 17.2% | 2025-08-05 16:04:16 | 바로가기 |
| Molecular Genetics and Metabolism Reports | ELSEVIER | N/A | 2214-4269 | SCIE | GENETICS & HEREDITY | 1,627 | 1.9 | Q3 | 64.1 | 35.9 | 123/191 | 1.9 | Q3 | 1.9 | 0.3 | 0.52 | 122/191 | Q3 | 36.39 | 0.003 | 0.583 | 0.613 | Q3 | 117 | 94.9% | 4.6 | 8.4 | 111 | 93.9% | 2025-08-05 16:03:19 | 바로가기 |
| MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS | ELSEVIER | 1386-1964 | 1879-2871 | SCIE | GENETICS & HEREDITY | 4,767 | 1.9 | Q3 | 64.1 | 35.9 | 123/191 | 2.2 | Q3 | 1.9 | 0.4 | 0.46 | 136/191 | Q3 | 29.06 | 0.000 | 0.108 | 0.505 | Q3 | 25 | 100.0% | 18.1 | 8.3 | 25 | 13.2% | 2025-08-05 16:03:19 | 바로가기 |
| Sahara J-Journal of Social Aspects of HIV-AIDS | TAYLOR & FRANCIS LTD | 1729-0376 | 1813-4424 | SSCI | HEALTH POLICY & SERVICES | 334 | 1.8 | Q3 | 64.1 | 35.9 | 80/124 | 1.6 | Q4 | 1.8 | 1.0 | 0.40 | 114/124 | Q4 | 8.47 | 0.000 | 0.023 | 0.386 | Q4 | 2 | 50.0% | 10.1 | N/A | 1 | 100.0% | 2025-08-05 16:03:26 | 바로가기 |
| Sexual and Relationship Therapy | ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD | 1468-1994 | 1468-1749 | SSCI | PSYCHOLOGY, CLINICAL | 1,093 | 1.4 | Q3 | 64.1 | 35.9 | 119/185 | 1.8 | Q3 | 1.0 | 0.6 | 0.43 | 138/185 | Q3 | 25.68 | 0.001 | 0.217 | 0.502 | Q3 | 23 | 91.3% | 7.0 | 8.7 | 21 | 10.5% | 2025-08-05 16:04:52 | 바로가기 |
| Small Enterprise Research | ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD | 1321-5906 | 1175-0979 | ESCI | BUSINESS | 428 | 1.8 | Q3 | 64.1 | 35.9 | 203/316 | 2.1 | Q3 | 1.7 | 0.4 | 0.35 | 222/317 | Q3 | 30.13 | 0.000 | 0.059 | 0.341 | Q3 | 10 | 100.0% | 6.0 | 10.0 | 10 | 20.0% | 2025-08-05 16:02:36 | 바로가기 |
| Tissue Engineering Part A | MARY ANN LIEBERT, INC | 1937-3341 | 1937-335X | SCIE | CELL & TISSUE ENGINEERING | 7,361 | 2.9 | Q3 | 64.1 | 35.9 | 21/32 | 3.3 | Q3 | 2.8 | 0.7 | 0.58 | 19/32 | Q3 | 42.19 | 0.003 | 0.573 | 0.625 | Q3 | 100 | 100.0% | 10.2 | 7.5 | 100 | 2.2% | 2025-08-05 16:02:37 | 바로가기 |
| Transnational Corporations Review | ELSEVIER SCIENCE INC | 1918-6444 | 1925-2099 | ESCI | BUSINESS | 531 | 1.8 | Q3 | 64.1 | 35.9 | 203/316 | 2.1 | Q3 | 1.6 | 1.0 | 0.48 | 191/317 | Q3 | 39.91 | 0.000 | 0.094 | 0.317 | Q4 | 32 | 90.6% | 4.3 | 10.3 | 29 | 63.2% | 2025-08-05 16:02:36 | 바로가기 |
| VIRUS GENES | SPRINGER | 0920-8569 | 1572-994X | SCIE | GENETICS & HEREDITY | 2,740 | 1.9 | Q3 | 64.1 | 35.9 | 123/191 | 1.9 | Q3 | 1.8 | 0.4 | 0.46 | 136/191 | Q3 | 29.06 | 0.001 | 0.331 | 0.450 | Q4 | 85 | 92.9% | 9.3 | 9.0 | 79 | 11.1% | 2025-08-05 16:03:19 | 바로가기 |
| Welding International | TAYLOR & FRANCIS LTD | 0950-7116 | 1754-2138 | ESCI | METALLURGY & METALLURGICAL ENGINEERING | 1,090 | 1.2 | Q3 | 64.1 | 35.9 | 62/96 | N/A | N/A | 1.0 | 0.5 | 0.25 | 63/96 | Q3 | 34.90 | 0.000 | 0.045 | N/A | N/A | 84 | 88.1% | 12.9 | 7.5 | 74 | 2.3% | 2025-08-05 16:04:12 | 바로가기 |
| APMIS | WILEY | 0903-4641 | 1600-0463 | SCIE | IMMUNOLOGY | 4,269 | 2.6 | Q3 | 64.2 | 35.8 | 118/183 | 2.8 | Q3 | 2.6 | 0.6 | 0.62 | 104/183 | Q3 | 43.44 | 0.002 | 0.421 | 0.636 | Q3 | 100 | 75.0% | 10.3 | 8.0 | 75 | 42.5% | 2025-08-05 16:03:35 | 바로가기 |
| Asia Policy | NATL BUREAU ASIAN RESEARCH | 1559-0968 | 1559-2960 | ESCI | INTERNATIONAL RELATIONS | 347 | 0.9 | Q3 | 64.2 | 35.8 | 109/169 | N/A | N/A | 0.8 | 0.1 | 0.44 | 118/169 | Q3 | 30.47 | 0.001 | 0.122 | N/A | N/A | 56 | 96.4% | 5.3 | 2.8 | 54 | 0.0% | 2025-08-05 16:03:39 | 바로가기 |
| Contemporary Southeast Asia | INST SOUTHEAST ASIAN STUDIES-ISEAS | 0129-797X | 1793-284X | SSCI | INTERNATIONAL RELATIONS | 592 | 0.9 | Q3 | 64.2 | 35.8 | 109/169 | 1.2 | Q3 | 0.9 | 1.2 | 0.61 | 95/169 | Q3 | 44.08 | 0.000 | 0.110 | 0.563 | Q3 | 13 | 92.3% | 11.2 | 8.1 | 12 | 0.0% | 2025-08-05 16:03:39 | 바로가기 |
| Current Opinion in Allergy and Clinical Immunology | LIPPINCOTT WILLIAMS & WILKINS | 1528-4050 | 1473-6322 | SCIE | IMMUNOLOGY | 2,878 | 2.6 | Q3 | 64.2 | 35.8 | 118/183 | 2.5 | Q3 | 2.4 | 0.6 | 0.42 | 140/183 | Q4 | 23.77 | 0.002 | 0.466 | 0.694 | Q3 | 76 | 0.0% | 8.9 | 4.9 | 0 | 8.3% | 2025-08-05 16:03:35 | 바로가기 |
페이지 이동: